BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 17019415)

  • 1. Avoiding surgery for thyroid eye disease.
    Meyer PA
    Eye (Lond); 2006 Oct; 20(10):1171-7. PubMed ID: 17019415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of Grave's ophthalmopathy with high doses of corticosteroids].
    Cirić J; Zarković M; Stojanović M; Pepenezić Z; Randjelović G; Gligorović M; Trbojević B; Drezgić M; Nesović M
    Srp Arh Celok Lek; 2000; 128(5-6):179-83. PubMed ID: 11089418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of thyroid ophthalmopathy--a clinical case].
    Andrei S; Zemba M; Zugravu V; Enache V; Renetti A; Spiroiu C
    Oftalmologia; 2007; 51(1):49-55. PubMed ID: 17605272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Orbital-bony decompression in patients with dysthyroid orbitopathy--first Croatian experiences].
    Juri J; Stiglmayer N; Kuzman T
    Acta Med Croatica; 2006; 60(2):83-6. PubMed ID: 16848193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postural visual obscurations in patients with inactive thyroid eye disease; a variant of 'hydraulic' disease.
    Rose GE
    Eye (Lond); 2006 Oct; 20(10):1178-85. PubMed ID: 17019416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical or medical decompression as a first-line treatment of optic neuropathy in Graves' ophthalmopathy? A randomized controlled trial.
    Wakelkamp IM; Baldeschi L; Saeed P; Mourits MP; Prummel MF; Wiersinga WM
    Clin Endocrinol (Oxf); 2005 Sep; 63(3):323-8. PubMed ID: 16117821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Radiation therapy for thyroid-associated ophthalmopathy].
    Luo QL; He WM; Tang L; Chen LJ
    Zhonghua Yan Ke Za Zhi; 2006 Mar; 42(3):218-21. PubMed ID: 16643752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Combined therapy with cyclosporin A and cortisone in endocrine Basedow endocrine orbitopathy: successful use in compressive optic neuropathy].
    Weissel M; Zielinski CC; Hauff W; Till P
    Acta Med Austriaca; 1993; 20(1-2):9-13. PubMed ID: 8475683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced risk of compressive optic neuropathy using orbital radiotherapy in patients with active thyroid eye disease.
    Shams PN; Ma R; Pickles T; Rootman J; Dolman PJ
    Am J Ophthalmol; 2014 Jun; 157(6):1299-305. PubMed ID: 24582992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined orbital irradiation and systemic steroids compared with systemic steroids alone in the management of moderate-to-severe Graves' ophthalmopathy: a preliminary study.
    Ng CM; Yuen HK; Choi KL; Chan MK; Yuen KT; Ng YW; Tiu SC
    Hong Kong Med J; 2005 Oct; 11(5):322-30. PubMed ID: 16219950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined radiotherapy and medical immunosuppression in the management of thyroid eye disease.
    Claridge KG; Ghabrial R; Davis G; Tomlinson M; Goodman S; Harrad RA; Potts MJ
    Eye (Lond); 1997; 11 ( Pt 5)():717-22. PubMed ID: 9474324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endoscopic orbital decompression for optic neuropathy in thyroid ophthalmopathy.
    Tang IP; Prepageran N; Subrayan V; Tajunisah I
    Med J Malaysia; 2008 Oct; 63(4):337-8. PubMed ID: 19385499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of intravenous methylprednisolone therapy vs. oral methylprednisolone therapy in patients with Graves' ophthalmopathy.
    Aktaran S; Akarsu E; Erbağci I; Araz M; Okumuş S; Kartal M
    Int J Clin Pract; 2007 Jan; 61(1):45-51. PubMed ID: 16889639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Management of Graves' ophthalmopathy].
    Schalin-Jäntti C
    Duodecim; 2010; 126(20):2431-7. PubMed ID: 21125757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical manifestations of thyroid ophthalmopathy].
    Fernández Hermida RV; Pinar S; Muruzábal N
    An Sist Sanit Navar; 2008; 31 Suppl 3():45-56. PubMed ID: 19169294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Decompression surgery for endocrine orbitopathy].
    Kahaly GJ; Bumb P; Pitz S; Scheurle C; Ponto KA; Lingl K; Hommel G; Müller-Forell W; Weber MM; Mann WJ
    Med Klin (Munich); 2007 Sep; 102(9):714-9. PubMed ID: 17879009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No light perception vision from compressive thyroid orbitopathy.
    Hornbeak DM; Tamhankar MA; Eckstein LA
    Orbit; 2014 Feb; 33(1):72-4. PubMed ID: 24206015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of Graves' ophthalmopathy.
    Wiersinga WM
    Nat Clin Pract Endocrinol Metab; 2007 May; 3(5):396-404. PubMed ID: 17452966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Severe Graves' ophthalmopathy accompanied by myasthenia gravis].
    Maeda K; Kume S; Nishio Y; Maeda S; Nishida Y; Suzuki M; Nakaguchi T; Kawabata T; Hashimoto O; Hisanaga T; Kashiwagi A; Yasuda H
    Rinsho Shinkeigaku; 2006 Apr; 46(4):266-9. PubMed ID: 16768093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Viral conjunctivitis interfering with the clinical activity score and management of thyroid ophthalmopathy.
    Boboridis KG; Konstas AG; Krassas GE; Georgiadis NS
    Orbit; 2006 Mar; 25(1):27-9. PubMed ID: 16527772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.